KEVIN P STARR Insider Trading $SAGE Sage Therapeutics, Inc.
Get free email notifications about insider trading for KEVIN P STARR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KEVIN P STARR. KEVIN P STARR is Director in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and Director in ZAFGEN, INC. ($ZFGN) and 10% Owner in CytomX Therapeutics, Inc. ($CTMX) and Director in MyoKardia Inc ($MYOK) and 10% Owner in Blueprint Medicines Corp ($BPMC) and in Sage Therapeutics, Inc. ($SAGE) and Director in Sage Therapeutics, Inc. ($SAGE) and 10% Owner in Global Blood Therapeutics, Inc. ($GBT) and Director in Global Blood Therapeutics, Inc. ($GBT) and 10% Owner in Editas Medicine, Inc. ($EDIT).
KEVIN P STARR in Sage Therapeutics, Inc.
Trading Symbol: SAGEIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KEVIN P STARR:
Holdings: 320,659 shares
Current Value: $15,295,434
Latest Transaction: Jun 17 2021
$SAGE Market Capitalization: $1.75B
$SAGE Previous Close: $47.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of KEVIN P STARR in Sage Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALNY, BPMC, CTMX, EDIT, GBT, LRMR, MYOK, SAGE
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 17 2021 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Buy | P | 56.05 | 17,842 | 999,983 | 320,659 | 302.8 K to 320.7 K (+5.89 %) | |
Jun 11 2020 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Option Exercise | A | 36.47 | 10,000 | 364,700 | 10,000 | ||
Jun 06 2019 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Option Exercise | A | 177.41 | 10,000 | 1,774,100 | 10,000 | ||
Apr 19 2018 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | S | 168.28 | 24,000 | 4,038,650 | 302,817 | 326.8 K to 302.8 K (-7.34 %) |
Apr 19 2018 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | S | 169.25 | 35,000 | 5,923,600 | 326,817 | 361.8 K to 326.8 K (-9.67 %) |
Feb 20 2018 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 510,554 | 0 | 37,362 | 547.9 K to 37.4 K (-93.18 %) |
Sep 27 2017 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 545,000 | 0 | 547,916 | 1.1 M to 547.9 K (-49.87 %) |
Jul 19 2017 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 800,000 | 0 | 1,092,916 | 1.9 M to 1.1 M (-42.26 %) |
Jun 09 2017 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Option Exercise | A | 72.74 | 14,000 | 1,018,360 | 14,000 | ||
Jan 24 2017 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 1,000,000 | 0 | 1,892,916 | 2.9 M to 1.9 M (-34.57 %) |
Aug 19 2016 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 1,000,000 | 0 | 2,892,916 | 3.9 M to 2.9 M (-25.69 %) |
Jun 24 2016 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Option Exercise | A | 28.35 | 13,922 | 394,689 | 13,922 | ||
May 18 2016 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | S | 31.25 | 850,000 | 26,562,500 | 3,892,916 | 4.7 M to 3.9 M (-17.92 %) |
Nov 13 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Buy | J | 0.00 | 15,986 | 0 | 65,227 | 49.2 K to 65.2 K (+32.46 %) |
Nov 13 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 109,832 | 0 | 0 | 109.8 K to 0 (-100.00 %) |
Nov 13 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Buy | J | 0.00 | 109,832 | 0 | 109,832 | 0 to 109.8 K |
Nov 13 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 1,700,000 | 0 | 4,742,916 | 6.4 M to 4.7 M (-26.39 %) |
Aug 18 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Buy | J | 0.00 | 21,910 | 0 | 49,241 | 27.3 K to 49.2 K (+80.17 %) |
Aug 18 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 150,546 | 0 | 0 | 150.5 K to 0 (-100.00 %) |
Aug 18 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Buy | J | 0.00 | 150,546 | 0 | 150,546 | 0 to 150.5 K |
Aug 18 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 2,330,157 | 0 | 6,442,916 | 8.8 M to 6.4 M (-26.56 %) |
Jun 22 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Buy | J | 0.00 | 9,403 | 0 | 27,331 | 17.9 K to 27.3 K (+52.45 %) |
Jun 22 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 64,607 | 0 | 0 | 64.6 K to 0 (-100.00 %) |
Jun 22 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Buy | J | 0.00 | 64,607 | 0 | 64,607 | 0 to 64.6 K |
Jun 22 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Director | Sell | J | 0.00 | 1,000,000 | 0 | 8,773,073 | 9.8 M to 8.8 M (-10.23 %) |
May 29 2015 | SAGE | Sage Therapeutics, ... | STARR KEVIN P | Option Exercise | A | 73.13 | 13,922 | 1,018,116 | 13,922 |
Page: 1